Clinical Trial Update: Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tumor necrosis factor (TNF) inhibitors to reduce mortality in people with HIV infection and tuberculous meningitis. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculous Meningitis

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Tuberculous Meningitis, HIV I Infection | Phase 2 | Status: RECRUITING